Are you interested in the latest news, trends and events regarding antibodies, custom ELISAs and HCP? Then you have come to the right spot.
The BioGenes team is happy to present you with the latest and most interesting topics in our news & trends blog. Please use the filter option on the right to find specific topics of choice.
Is there any feedback that you would like to share with us? In that case please contact us.
HCP,
Q&A: How are process-specific Host Cell Protein ELISAs developed at BioGenes?
Answer: Generic kits are broadly used for the measurement of HCPs in biologicals during the downstream process. However, for the later stages, process…
HCP,
Q&A: How to decide which generic HCP ELISA type is suitable for HCP monitoring in my biological drug manufacturing process?
Answer: We recommend working with generic ELISA kits during early drug development phases. The proteins of host cells are specific for a given process…
Company,
We are celebrating 30 Years of BioGenes
This summer, BioGenes is turning 30 and our celebrations would not be complete without you!
Thank you for being a part of our journey and for making…
HCP,
Q&A: How are generic ELISA kits developed and what is special about the BioGenes 360 approach?
Answer: The development of generic HCP ELISA kits involves the following steps:
PK & Immunogenicity,
New Poster: Establishment of an assay to assess the immunogenicity of a therapeutic antisense oligonucleotide in clinical samples
Together with FyoniBio, a specialist in bioassay development and validation for analysis of clinical samples, BioGenes is offering services in the…
Analytics,
Q&A: Which are the advantages and limitations of orthogonal methods for HCP monitoring?
Answer: There is an increased need for simultaneous HCP detection and identification to improve HCP risk assessment.
This can be achieved using…